Obesity / weight management clinical trials recruiting in New York

12 recruiting obesity / weight management trials match in New York. Showing 12.

• Maternal Smoking Cessation and Pediatric Obesity PreventionRecruiting

  N/A · State University of New York at Buffalo · Buffalo, New York

• A Dose Escalation Study of AV-380 in Cancer Patients With CachexiaRecruiting

  Phase 1 · AVEO Pharmaceuticals, Inc. · Shirley, New York

• AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose WeightRecruiting

  Phase 3 · Novo Nordisk A/S · New York, New York

• Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or ObesityRecruiting

  Phase 3 · Amgen · Binghamton, New York

• Efficacy and Safety of MET097 Once-Weekly in People With Overweight or ObesityRecruiting

  Phase 3 · Pfizer · Scottsdale, Arizona

• A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)Recruiting

  Phase 3 · Pfizer · Anaheim, California

• CHIME: Comparing Health Interventions for Maternal EquityRecruiting

  N/A · Stanford University · Flushing, New York

• Hydration Intervention to Decrease Side Effects Associated With GLP - 1 RA TherapyRecruiting

  N/A · State University of New York at Buffalo · Buffalo, New York

• Developmental Trajectories of Reinforcer Pathology and Childhood ObesityRecruiting

  N/A · State University of New York at Buffalo · Buffalo, New York

• Chronic Widespread Pain After Rapid Weight Loss in Non-Hispanic Black and Hispanic/Latino/a/x AdultsRecruiting

  N/A · New York University · New York, New York

• Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or OverweightRecruiting

  Phase 3 · Eli Lilly and Company · New York, New York

• Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b StudyRecruiting

  Phase 3 · Eli Lilly and Company · New York, New York

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.